Exact Mass: 725.3411086

Exact Mass Matches: 725.3411086

Found 38 metabolites which its exact mass value is equals to given mass value 725.3411086, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

3-Formyl Rifamycin

26-formyl-2,15,17,27,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.1^{4,7}.0^{5,28}]triaconta-1(28),2,4,9,19,21,25(29),26-octaen-13-yl acetate

C38H47NO13 (725.3047252)

Dalargin

2-{2-[2-(2-{2-[2-amino-3-(4-hydroxyphenyl)propanamido]propanamido}acetamido)-3-phenylpropanamido]-4-methylpentanamido}-5-[(diaminomethylidene)amino]pentanoic acid

C35H51N9O8 (725.3860406)

14-O-acetyl-8-O-methyl-18-O-2-(2-methyl-4-oxo-4H-quinazoline-3-yl)benzoylcammaconine

C42H51N3O8 (725.3675966000001)

3-Formyl Rifamycin

3-formyl Rifamycin SV

C38H47NO13 (725.3047252)

D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D012294 - Rifamycins relative retention time with respect to 9-anthracene Carboxylic Acid is 1.493 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.492

CE-108E

[C36H57N2O13]+ (725.3860452)

3-Formylrifampin

3-Formyl Rifamycin

C38H47NO13 (725.3047252)

(D-Ala2)-leucine enkephalin-arg

(D-Ala2)-Leu-Enkephalin-Arg trifluoroacetate salt

C35H51N9O8 (725.3860406)

Dalargin is a potent δ-opioid receptor agonist. Dalargin mitigates Gentamicin (HY-A0276)-induced cell death. Dalargin shows nephroprotective effects on Gentamicin (HY-A0276A)-induced kidney injury. Dalargin shows antiulcer activity[1][2][3]. Dalargin is a potent δ-opioid receptor agonist. Dalargin mitigates Gentamicin (HY-A0276)-induced cell death. Dalargin shows nephroprotective effects on Gentamicin (HY-A0276A)-induced kidney injury. Dalargin shows antiulcer activity[1][2][3].

24-demethoxycarbonyl-24-methylstreptovaricin C

C39H51NO12 (725.3411086)

3,15,27-Triamino-7,19-dihydroxy-10,22,34-trimethyl-31-oxido-1,13,25-trioxa-7,19,31-triazacyclohexatriaconta-9,21,33-triene-2,8,14,20,26,32-hexone

C33H53N6O12- (725.3721278)

[(9Z,19Z,21Z)-26-formyl-2,15,17,27,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl] acetate

[(9Z,19Z,21Z)-26-formyl-2,15,17,27,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl] acetate

C38H47NO13 (725.3047252)

(3S,3S,4R,6S,8R,8aR)-5-[2-(1-hydroxycycloheptyl)ethynyl]-6-[4-(2-hydroxyethoxy)phenyl]-1,2-dioxo-3,4-diphenyl-8-spiro[1H-indole-3,7-4,6,8,8a-tetrahydro-3H-pyrrolo[2,1-c][1,4]oxazine]carboxamide

C44H43N3O7 (725.3100847999999)

[(2R,3S,4S,5S,6R)-2-[[(1R,3S,9R,10S,13R,15E,17E,19E,21E,23R,25S,26R,27S)-26-carbamoyl-1,3,9,27-tetrahydroxy-10,13-dimethyl-7,11-dioxo-12,29-dioxabicyclo[23.3.1]nonacosa-15,17,19,21-tetraen-23-yl]oxy]-3,5-dihydroxy-6-methyloxan-4-yl]azanium

[(2R,3S,4S,5S,6R)-2-[[(1R,3S,9R,10S,13R,15E,17E,19E,21E,23R,25S,26R,27S)-26-carbamoyl-1,3,9,27-tetrahydroxy-10,13-dimethyl-7,11-dioxo-12,29-dioxabicyclo[23.3.1]nonacosa-15,17,19,21-tetraen-23-yl]oxy]-3,5-dihydroxy-6-methyloxan-4-yl]azanium

C36H57N2O13+ (725.3860452)